Search results
Results from the WOW.Com Content Network
For premium support please call: 800-290-4726 more ways to reach us
On July 18, 2006, pharmaceutical company Novartis announced it would be building a manufacturing facility in Holly Springs and employing about 350 to produce flu vaccines using new technologies. The manufacturing facility was built on 167 acres (0.68 km 2 ) in Holly Springs Business Park off N.C. 55 Bypass.
In January 2009, the United States Department of Health and Human Services awarded Novartis a $486 million contract for construction of the first US plant to produce cell-based influenza vaccine, to be located in Holly Springs, North Carolina.
The plan was to manufacture the vaccine in Holly Springs, North Carolina. The United States government provided $500 million in construction costs and guaranteed vaccine purchases. [16] Novartis' flu vaccine unit was sold to CSL Limited in 2014, and was placed under CSL subsidiary, bioCSL (Seqirus).
It’s about 1.5 miles west of Holly Springs Towne Center on N.C. 55. It’s expected to bring up to 725 jobs to the area over five years. The jobs would pay an average annual wage of $99,848.
Swiss pharmaceutical company Novartis (NVS) announced Tuesday that it had discontinued the development of two drugs -- the hepatitis C treatment Zalbin, and the antifungal agent Mycograb -- as ...
Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline. [2]
Lighter Side. Medicare. new